A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/139, 167/103
A61K 39/395 (2006.01) A61K 38/17 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2003455
A method of immunotherapy stimulates the T cell CD28 surface molecule to enhance T cell proliferation and increase overall lymphokine levels or to increase cellular production of human T H1 lymphokines or both. The method is selective for the induction of activated T cell mediated immune responses and enhances immune function even in the presence of immunosuppresants.
June Carl H.
Ledbetter Jeffrey A.
Lindsten Tullia
Thompson Craig B.
Bristol-Myers Company
Bristol-Myers Squibb Company
Macrae & Co.
The Regents Of The University Of Michigan
LandOfFree
Immunotherapy involving cd28 stimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapy involving cd28 stimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapy involving cd28 stimulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1856892